Zika and Sendai Virus Infections in Human Keratinocytes
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Duke University
Other organizations : University of Michigan–Ann Arbor, University of North Carolina at Chapel Hill, Duke Institute for Health Innovation
Variable analysis
- Zika virus strain (Zika virus–Dakar (DAK) and Zika virus–French Polynesia (PF))
- Sendai virus strain Cantell
- Infection outcomes in human keratinocytes
- Serum-free media conditions for 1 hour during in vitro Zika and Sendai virus infections
- Vero cells (CCL-81) from the American Type Culture Collection (ATCC), verified as mycoplasma free
- Positive control: Not specified.
- Negative control: Not specified.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!